Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma

Abstract

Array-CGH allowed identification of three prognostic groups with low, intermediate and high risk of developing metastasis. Array-CGH is a reliable and inexpensive method for uveal melanoma prognosis. This method is now currently used in France.